The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Stephen R. Marder

Building 210

Room 130

West Los Angeles VA Healthcare Center

11301 Wilshire Blvd

USA

[email]@ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Building 210, Room 130, West Los Angeles VA Healthcare Center, 11301 Wilshire Blvd, USA. 2010
  • Veteran's Affairs Veteran's Integrated Service Networks 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, USA. 2002 - 2007
  • Semel Institute of Neuroscience, UCLA, Los Angeles, Calif, USA. 2006 - 2007
  • Semel Institute of Neuroscience and Human Behavior at UCLA and the Mental Illness Research, Education, and Clinical Center (MIRECC), West Los Angeles VA Healthcare Center, USA. 2006
  • Department of Veterans Affairs Greater Los Angeles Healthcare System, USA. 2004
  • VA Greater Los Angeles Health Care System, West Los Angeles Health Center and the Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA 90073, USA. 2002 - 2003
  • Department of Psychiatry, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, 90024, USA. 2003
  • Psychiatry Service, West Los Angeles Veterans Affairs Medical Center, CA 90073, USA. 1999
  • West Los Angeles VA Medical Center, CA 90073, USA. 1996

References

  1. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. Marder, S.R., Sorsaburu, S., Dunayevich, E., Karagianis, J.L., Dawe, I.C., Falk, D.M., Dellva, M.A., Carlson, J.L., Cavazzoni, P.A., Baker, R.W. J. Clin. Psychiatry (2010) [Pubmed]
  2. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Marder, S.R., Kramer, M., Ford, L., Eerdekens, E., Lim, P., Eerdekens, M., Lowy, A. Biol. Psychiatry (2007) [Pubmed]
  3. Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. Marder, S.R., West, B., Lau, G.S., Pultz, J.A., Pikalov, A., Marcus, R.N., Gutierrez-Esteinou, R., Crandall, D.T. J. Clin. Psychiatry (2007) [Pubmed]
  4. The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia. Marder, S.R. Dialogues. Clinical. Neuroscience (2006) [Pubmed]
  5. Drug initiatives to improve cognitive function. Marder, S.R. J. Clin. Psychiatry (2006) [Pubmed]
  6. Subjective experiences on antipsychotic medications: synthesis and conclusions. Marder, S.R. Acta. Psychiatr. Scand. Suppl (2005) [Pubmed]
  7. Physical health monitoring of patients with schizophrenia. Marder, S.R., Essock, S.M., Miller, A.L., Buchanan, R.W., Casey, D.E., Davis, J.M., Kane, J.M., Lieberman, J.A., Schooler, N.R., Covell, N., Stroup, S., Weissman, E.M., Wirshing, D.A., Hall, C.S., Pogach, L., Pi-Sunyer, X., Bigger, J.T., Friedman, A., Kleinberg, D., Yevich, S.J., Davis, B., Shon, S. Am. J. Psychiatry (2004) [Pubmed]
  8. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Marder, S.R., Fenton, W. Schizophr. Res. (2004) [Pubmed]
  9. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Marder, S.R., McQuade, R.D., Stock, E., Kaplita, S., Marcus, R., Safferman, A.Z., Saha, A., Ali, M., Iwamoto, T. Schizophr. Res. (2003) [Pubmed]
  10. Overview of partial compliance. Marder, S.R. J. Clin. Psychiatry (2003) [Pubmed]
  11. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate. Marder, S.R., Aravagiri, M., Wirshing, W.C., Wirshing, D.A., Lebell, M., Mintz, J. Schizophr. Res. (2002) [Pubmed]
  12. Can clinical practice guide a research agenda?. Marder, S.R. Schizophr. Bull (2002) [Pubmed]
  13. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Marder, S.R., Essock, S.M., Miller, A.L., Buchanan, R.W., Davis, J.M., Kane, J.M., Lieberman, J., Schooler, N.R. Schizophr. Bull (2002) [Pubmed]
  14. Antipsychotic drugs and relapse prevention. Marder, S.R. Schizophr. Res. (1999) [Pubmed]
  15. Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. Marder, S.R., Wirshing, W.C., Mintz, J., McKenzie, J., Johnston, K., Eckman, T.A., Lebell, M., Zimmerman, K., Liberman, R.P. Am. J. Psychiatry (1996) [Pubmed]
 
WikiGenes - Universities